Skip to content

A randomized, controlled, multicentre study to investigate the effectiveness of digital cognitive training in subjects with post-stroke cognitive impairment

A randomized, controlled, multicentre study to investigate the effectiveness of digital cognitive training in subjects with post-stroke cognitive impairment

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082971
Enrollment
Unknown
Registered
2024-04-12
Start date
2023-03-17
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PSCI

Interventions

Intervention group 1:Digital therapeutics for post-stroke cognitive impairment (AMD201)
Intervention group 2:Healthe ducation videos

Sponsors

Beijing Tiantan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age = 18 years old 2. Ischemic or hemorrhagic stroke confirmed by clinical and radiological evidence 3. 3-9 months after first stroke 4. MoCA-B=24(education of > 12 years),MoCA-B=22(education of 7-12 years)or MoCA-B=19(education of 1-6 years) 5. mRS = 3 (Moderate disability) 6. Subjects taking Acetylcholinesterase Inhibitors, NMDA Receptor Antagonists or Sodium Oligomannate capsules should be on stable doses more than 30 days before randomization. 7. Able to complete screening game 8. Written informed consent

Exclusion criteria

Exclusion criteria: 1. Cognitive decline before stroke (IQCODE average =3.19 or total score =51 ) 2. HAMD-17 > 17 3. Have other diseases affecting cognition 4. Received cognitive training within one month prior to enrollment. 5. Unstable conditions or concomitant epilepsy or psychiatric symptoms 6. Impairment of color sensation, vision, hearing, language or extremity movement, not able to complete the study as judged by investigator 7. Use of prohibited medication within 30 days prior to enrollment 8. lliterate 9. Other situations not suitable for study by investigator’s judgement

Design outcomes

Primary

MeasureTime frame
ADAS-Cog14 (week12);

Secondary

MeasureTime frame
ADAS-Cog14 (week6);VADAS-Cog14 (week6 week12);MoCA-B (week6 week12);TMT-A (week12);HAMD-17 (week12);IADL (week12);

Countries

China

Contacts

Public ContactQidong Chen

Beijing Tiantan Hospital, Capital Medical University

13621196263@163.com+86 136 2119 6263

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026